Peter Goadsby
Peter Goadsby
Email verificata su
TitoloCitata daAnno
The international classification of headache disorders, (beta version)
Headache Classification Committee of the International Headache Society (IHS)
Cephalalgia 33 (9), 629-808, 2013
Migraine—current understanding and treatment
PJ Goadsby, RB Lipton, MD Ferrari
New England journal of medicine 346 (4), 257-270, 2002
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
PJ Goadsby, L Edvinsson, R Ekman
Annals of Neurology: Official Journal of the American Neurological …, 1990
Hypothalamic activation in cluster headache attacks
A May, A Bahra, C Büchel, RSJ Frackowiak, PJ Goadsby
The Lancet 352 (9124), 275-278, 1998
Mechanism and management of headache
JW Lance, PJ Goadsby
Butterworth-Heinemann, 1998
Calcitonin gene–related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine
J Olesen, HC Diener, IW Husstedt, PJ Goadsby, D Hall, U Meier, ...
New England Journal of Medicine 350 (11), 1104-1110, 2004
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
MD Ferrari, KI Roon, RB Lipton, PJ Goadsby
The Lancet 358 (9294), 1668-1675, 2001
New appendix criteria open for a broader concept of chronic migraine
Headache Classification Committee, J Olesen, MG Bousser, HC Diener, ...
Cephalalgia 26 (6), 742-746, 2006
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats
PJ Goadsby, L Edvinsson
Annals of Neurology: Official Journal of the American Neurological …, 1993
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.
PJ Goadsby, RB Lipton
Brain: a journal of neurology 120 (1), 193-209, 1997
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine
M Dichgans, T Freilinger, G Eckstein, E Babini, B Lorenz-Depiereux, ...
The Lancet 366 (9483), 371-377, 2005
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
PJ Goadsby, L Edvinsson, R Ekman
Annals of Neurology: Official Journal of the American Neurological …, 1988
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
HC Diener, DW Dodick, SK Aurora, CC Turkel, RE DeGryse, RB Lipton, ...
Cephalalgia 30 (7), 804-814, 2010
EFNS guideline on the drug treatment of migraine–revised report of an EFNS task force
S Evers, J Afra, A Frese, PJ Goadsby, M Linde, A May, PS Sándor
European journal of neurology 16 (9), 968-981, 2009
Guidelines for controlled trials of drugs in migraine
International Headache Society Clinical Trials Subcommittee, ...
Cephalalgia 20 (9), 765-786, 2000
Brainstem activation specific to migraine headache
A Bahra, MS Matharu, C Buchel, RSJ Frackowiak, PJ Goadsby
The lancet 357 (9261), 1016-1017, 2001
Human in vivo evidence for trigeminovascular activation in cluster headache Neuropeptide changes and effects of acute attacks therapies
PJ Goadsby, L Edvinsson
Brain 117 (3), 427-434, 1994
The international classification of headache disorders
J Olesen
Headache: The Journal of Head and Face Pain 48 (5), 691-693, 2008
Triptans (serotonin, 5‐HT1B/1D agonists) in migraine: detailed results and methods of a meta‐analysis of 53 trials
MD Ferrari, PJ Goadsby, KI Roon, RB Lipton
Cephalalgia 22 (8), 633-658, 2002
Correlation between structural and functional changes in brain in an idiopathic headache syndrome
A May, J Ashburner, C Büchel, DJ McGonigle, KJ Friston, RSJ Frackowiak, ...
Nature medicine 5 (7), 836, 1999
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20